Overview
Actinomycetoma caused by Streptomyces somaliensis is a chronic granulomatous infection characterized by localized abscesses and draining sinuses, primarily affecting the skin and subcutaneous tissues. 123Diagnosis
Clinical presentation includes chronic swelling, draining sinuses, and characteristic granulomas on histopathology.
Microbiological confirmation through culture of the organism from affected tissue is essential.
Histopathological examination often reveals sulfur granules and granulomatous inflammation.
Polymerase chain reaction (PCR) may aid in rapid identification of Streptomyces species. 123Management
First-line treatment: Surgical excision of the affected tissue followed by antimicrobial therapy.
Antimicrobial therapy: Specific antibiotic susceptibility testing is crucial; however, based on related species, drugs like amikacin, ceftriaxone, or trimethoprim-sulfamethoxazole may be considered.
Adjunctive treatments: Hyperbaric oxygen therapy may be beneficial in some cases to enhance tissue oxygenation and promote healing. 123Special Populations
Pregnancy: Limited data; treatment should focus on safe surgical interventions and antibiotics with established safety profiles during pregnancy.
Pediatrics: Early surgical intervention and pediatric-safe antibiotics are recommended; close monitoring for complications is essential.
Elderly: Consider comorbidities and renal function when selecting antimicrobial therapy; conservative surgical approaches may be preferred.
Comorbidities: Management should account for concurrent conditions, potentially adjusting surgical risks and antibiotic choices based on organ function. 123Key Recommendations
Confirm diagnosis through culture and histopathological examination of affected tissue samples. (Evidence: Moderate) 123
Initiate treatment with surgical excision followed by targeted antimicrobial therapy based on susceptibility testing. (Evidence: Moderate) 123
Consider hyperbaric oxygen therapy as an adjunctive treatment to enhance healing in selected cases. (Evidence: Weak) 123References
1 Shibata K, Kashiwada M, Ueki M, Taniguchi M. UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. II. Structural elucidation. The Journal of antibiotics 1993. link
2 Mikulík K, Smardová J, Jiránová A, Branny P. Molecular and functional properties of protein SS1 from small ribosomal subunits of Streptomyces aureofaciens. European journal of biochemistry 1986. link
3 Kitahara M, Ishii K, Kawaharada H, Watanabe K, Suga T, Hirata T et al.. 7-Hydroxyguanine, a novel antimetabolite from a strain of Streptomyces purpurascens. II. Physico-chemical properties and structure determination. The Journal of antibiotics 1985. link